Business · 02/02/2015Updated: 10/17/2026 · 1 min read

FDA Clears LYMPHAZURIN (Isosulfan Blue) Injectable and Other Drug Products for Continued Sale

The US Food and Drug Administration (FDA) has officially stated that LYMPHAZURIN (Isosulfan Blue) Injectable and other listed drug products were not withdrawn from the market due to safety or efficacy concerns, allowing the FDA to continue approving abbreviated new drug applications (ANDAs) for these products.